Bleakley Financial Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.56M | Buy |
359,366
+32,794
| +10% | +$507K | 0.14% | 137 |
|
|
2025
Q1 | $4.86M | Buy |
326,572
+8,232
| +3% | +$122K | 0.16% | 129 |
|
|
2024
Q4 | $4.21M | Sell |
318,340
-16,830
| -5% | -$223K | 0.13% | 141 |
|
|
2024
Q3 | $4.77M | Buy |
335,170
+35,186
| +12% | +$500K | 0.15% | 118 |
|
|
2024
Q2 | $3.88M | Buy |
299,984
+11,449
| +4% | +$148K | 0.11% | 172 |
|
|
2024
Q1 | $4.01M | Buy |
288,535
+46,182
| +19% | +$641K | 0.12% | 175 |
|
|
2023
Q4 | $3.46M | Buy |
242,353
+28,838
| +14% | +$412K | 0.11% | 177 |
|
|
2023
Q3 | $3.3M | Buy |
213,515
+738
| +0.3% | +$11.4K | 0.12% | 165 |
|
|
2023
Q2 | $3.34M | Buy |
212,777
+17,432
| +9% | +$274K | 0.1% | 174 |
|
|
2023
Q1 | $3.22M | Sell |
195,345
-6,814
| -3% | -$112K | 0.11% | 177 |
|
|
2022
Q4 | $3.15M | Buy |
+202,159
| New | +$3.15M | 0.11% | 169 |
|